Properties
Description
Decernotinib, soluble in DMSO and warmed ethanol and insoluble in water, is an available JAK small molecule inhibitor with potential antineoplastic activity. It targets JAK1, JAK1, JAK2, JAK3, and TYK2.
Molecular Formula
C18H19F3N6O
Targets
JAK1: 11 nM; JAK1: 11 nM (Ki); JAK2: 13 nM (Ki); JAK3: 2.5 nM (Ki); TYK2: 13 nM (Ki)
Solubility
DMSO: 70 mg/mL (178.39 mM); Water: Insoluble; Warmed ethanol: 18 mg/mL (45.87 mM)
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Decernotinib is used to explore its selectivity for inhibiting JAK3 and its potential benefits in treating rheumatoid arthritis.